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Abstract 
Short communication on t(X;14)(p11.4;q32.33) 
IGH/GPR34, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
B-cell non Hodgkin's lymphoma, including mucosa-
associated lymphoid tissue (MALT) lymphoma, nodal 
marginal zone lymphoma (nMZL) and gastric diffuse 
large B-cell lymphoma (DLBCL) 
Etiology 
Five cases have been reported so far: three females 
aged 60-69 years with primary MALT lymphoma 
involving the lung (two cases) and the parotid gland 
(one case), one 82-years old female with nMZL and 
one 82-years old male with gastric DLBCL. All 
patients had an underlying disorder, including Sjögren 
syndrome, a leukocytoclastic vasculitis and 
polyneuropathy, and Helicobacter Pylori-negative 
chronic gastritis with intestinal metaplasia. 
t(X;14)(p11.4;q32.33) is a rare translocation, being 
identified in 2 of 61 (3.3%) cases of MALT lymphoma, 
in one of 43 (2.3%) cases of nMZL and  
one of 19 (5.2) cases of extranodal DLBCL with clonal 
chromosomal abnormalities collected in Center for 
Human Genetics, KU Leuven, Leuven, Belgium 
(Baens et al., 2012). t(X;14)/IGH-GPR34 and the well 
known t(1;14)/IGH-BCL10, t(3;14)/IGH-FOXP1, 
t(11;18)/API2-MALT1 and t(14;18)/IGH-MALT1 are 
mutually exclusive in MALT lymphoma. 
Prognosis 
Unknown so far. 
Cytogenetics 
Cytogenetics molecular 
FISH and molecular studies demonstrated involvement 
of IGH/14q32.33 (Fig. 2a) and the GPR34 gene at 
Xp11.4 (Fig. 2b). 
Additional anomalies 
Cytogenetic data are available in four cases. The 
translocation occurred as the sole aberration in one case 
and was accompanied by 2 to 4 additional 
chromosomal abnormalities in the remaining cases. 
Subclonal duplication of der(14)t(X;14) or extra copy 
of IGH-GPR34 were found in three reported cases. 
 
 
Figure 1. Partial karyotype of t(X;14)(p11.4;q32.33). Duplication of der(14) occurs recurrently in t(X;14)-positive cases. 
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Figure 2. FISH analysis of t(X;14)(p11.4;q32.33). Applied probes: (a) LSI IGH; (b) BAC clones flanking the Xp11.4 breakpoint (RP11-
204C16/red and RP11-1174J21/green) (Baens et al., 2012). 
 
Genes involved and proteins 
GPR34 
Location 
Xp11.4 
Note 
Alias: G Protein-Coupled Receptor 34. 
DNA/RNA 
GPR34 consists of 3 exons, but only one is protein 
coding exon. Transcript length: 1924 bps. 
Transcription is from centromere to telomere. GPR34 
and the neighboring GPR82 are housed by intron 5 of 
CASK. Expression of GPR34 mRNA is ubiquitous in 
human tissues. 
Protein 
GPR34 codes for a G protein-coupled receptor that 
belongs to the largest family of cell surface molecules 
involved in signal transmission. These integral 
membrane proteins contain 7 putative transmembrane 
domains and mediate signals to the interior of the cell. 
The predicted 381-amino acid GPR34 has a calculated 
relative molecular mass of approximately 44 kDa, 
potential N-glycosylation sites within the extracellular 
N-terminal region, consensus acceptor phosphorylation 
sites for protein kinase A and C, and potential receptor-
specific kinase phosphorylation sites (multiple serine 
and threonine residues). The receptor encoded by 
GPR34 is most similar to the PY2 receptor subfamily 
of GPCR and it is evolutionarily conserved being 
present in all vertebrate classes. GPR34 protein is 
ubiquitously expressed; its highest levels of expression 
were found in placenta, spleen and brain (Engemaier et 
al., 2006). Experimental data suggest that GPR34 is 
required for adequate immune responses to antigen and 
pathogen contact.  
The natural ligand of GPR34 and downstream 
signaling pathways are largely unknown. 
IGH 
Location 
14q32.33 
Result of the chromosomal 
anomaly 
Hybrid gene 
Note 
Sequence analysis of one case with 
t(X;14)(p11.4;q32.33) showed that the Xp11.4 
breakpoint fell between exon 1 and 2 of GPR82, the 
gene located in close vicinity to GPR34, and the 
14q32.33 breakpoint occurred in the IGHA2 switch 
region, placing both genes in close proximity to the 
IGHA2 3' regulatory region enhancers, HS4, HS1, 
HS2, and HS3 (Ansell et al., 2012).  
Overexpression of GPR34 mRNA, but not GPR82 and 
CASK, indicates that the translocation targets GPR34.  
The functional consequences of the translocation 
remain elusive.  
Experimental data of Ansell et al. (2012) indicate that 
overexpression of GPR34 leads to constitutive 
activation of the ERK pathway, and also implicate a 
role of GPR34 in the activation of CREB, AP-1, PKC 
and NF-kB. Activation of NF-kB and ERK by GPR34, 
however, was not confirmed by Baens et al. (2012). 
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